Xolair 150 MG/ML syringeml

Ended Awarded

Contract number
SPE2DX24FBDYF
Awardee
Awarding agency
Obligated
$7,737

Award facts

Contract value 100% obligated
$7,737.00 Current and potential, with all options
Completion date 100% complete
Current and potential, with all options
NAICS code
325411 Medicinal and Botanical Manufacturing
PSC
6505 Drugs And Biologicals
Set-aside
No set-aside
Competition
Full and Open Competition Negotiated Proposal / Quote
Pricing
Firm Fixed Price
Place of performance
Park Ridge, IL 60068, USA

Award details come from SAM.gov/FPDS.

About this award

This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler. The contract is for the delivery of XOLAIR 150 MG/ML SYRINGEML, a specialized oncology medication, with a ceiling value of $7,737. The award is part of a larger indefinite delivery contract (IDC) valued at up to $499,999,999 under the DLA's SPE2DB program, which allows the DLA to issue delivery orders for a comprehensive range of pharmaceutical items to support the recurring medical supply needs of military health facilities worldwide. This contract has no set-aside designation.

Quick answers

Who was awarded contract SPE2DX24FBDYF?

SPE2DX24FBDYF was awarded to DMS Pharmaceutical Group Inc. by Medical Supply Chain (Troop Support) on July 2, 2024.

How much is contract SPE2DX24FBDYF worth?

The government has obligated $7,737 on SPE2DX24FBDYF.

Is contract SPE2DX24FBDYF an order under another contract?

Yes. SPE2DX24FBDYF is a delivery order under SPE2DX15D9348, an indefinite delivery contract.

Was contract SPE2DX24FBDYF competed?

The extent of competition for SPE2DX24FBDYF was full and open competition.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award